Insider · CIK 0001565020

VIVO VENTURES VII, LLC

Reports to the SEC for 5 companies · PALO ALTO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001565020

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2018-08-30	AIRXPANDERS INCP Purchase	10% Owner	PPurchase	+19.7M sh	$0.17	+$3.3M	36,195,409
2018-08-30	AIRXPANDERS INCP Purchase	10% Owner	PPurchase	+430K sh	$0.17	+$71.8K	788,873
2017-03-02	ACRSAclaris Therapeutics, Inc.S Sale	10% Owner	SSale	−2,666 sh	$31.20	−$83.2K	60,972
2017-03-02	ACRSAclaris Therapeutics, Inc.S Sale	10% Owner	SSale	−122K sh	$31.20	−$3.82M	2,797,597
2017-03-01	ACRSAclaris Therapeutics, Inc.S Sale	10% Owner	SSale	−2,133 sh	$30.98	−$66.1K	63,638
2017-03-01	ACRSAclaris Therapeutics, Inc.S Sale	10% Owner	SSale	−97.9K sh	$30.98	−$3.03M	2,919,931
2017-02-28	ACRSAclaris Therapeutics, Inc.S Sale	10% Owner	SSale	−4,266 sh	$30.50	−$130K	65,771
2017-02-28	ACRSAclaris Therapeutics, Inc.S Sale	10% Owner	SSale	−196K sh	$30.50	−$5.97M	3,017,798
2016-11-18	ACRSAclaris Therapeutics, Inc.S Sale	10% Owner	SSale	−9,598 sh	$22.72	−$218K	70,037
2016-11-18	ACRSAclaris Therapeutics, Inc.S Sale	10% Owner	SSale	−440K sh	$22.72	−$10M	3,213,532
2016-11-16	ACRSAclaris Therapeutics, Inc.S Sale	10% Owner	SSale	−9,765 sh	$27.30	−$267K	79,635
2016-11-16	ACRSAclaris Therapeutics, Inc.S Sale	10% Owner	SSale	−448K sh	$23.25	−$10.4M	3,653,934
2016-09-08	CDXSCODEXIS, INC.S Sale	10% Owner	SSale	−109K sh	$4.25	−$464K	5,181,885
2016-09-08	CDXSCODEXIS, INC.S Sale	10% Owner	SSale	−2,381 sh	$4.25	−$10.1K	112,940
2016-08-16	CDXSCODEXIS, INC.S Sale	10% Owner	SSale	−787 sh	$4.21	−$3,311.066	115,321
2016-08-16	CDXSCODEXIS, INC.S Sale	10% Owner	SSale	−36.1K sh	$4.21	−$152K	5,291,104
2016-08-15	CDXSCODEXIS, INC.S Sale	10% Owner	SSale	−1,066 sh	$4.27	−$4,556.084	116,108
2016-08-15	CDXSCODEXIS, INC.S Sale	10% Owner	SSale	−48.9K sh	$4.27	−$209K	5,327,211
2016-08-04	CDXSCODEXIS, INC.S Sale	10% Owner	SSale	−48.9K sh	$4.17	−$204K	5,376,145
2016-08-04	CDXSCODEXIS, INC.S Sale	10% Owner	SSale	−1,066 sh	$4.17	−$4,443.514	117,174
2016-08-03	CDXSCODEXIS, INC.S Sale	10% Owner	SSale	−640 sh	$4.30	−$2,750.912	118,240
2016-08-03	CDXSCODEXIS, INC.S Sale	10% Owner	SSale	−29.4K sh	$4.30	−$126K	5,425,079
2015-11-09	LITSLite Strategy, Inc.S Sale	10% Owner	SSale	−157K sh	$1.75	−$275K	3,163,105
2015-11-06	LITSLite Strategy, Inc.S Sale	10% Owner	SSale	−7,560 sh	$1.85	−$14K	3,320,457
2015-11-05	LITSLite Strategy, Inc.S Sale	10% Owner	SSale	−226K sh	$1.91	−$431K	3,328,017
2015-10-13	ACRSAclaris Therapeutics, Inc. · Series C Preferred StockC Conversion	10% Owner	CConversion	−1.35M sh	—	—	0
2015-10-13	ACRSAclaris Therapeutics, Inc.P Purchase	10% Owner	PPurchase	+445K sh	$11.00	+$4.89M	4,101,997
2015-10-13	ACRSAclaris Therapeutics, Inc.C Conversion	10% Owner	CConversion	+73.2K sh	—	—	79,705
2015-10-13	ACRSAclaris Therapeutics, Inc.P Purchase	10% Owner	PPurchase	+9,695 sh	$11.00	+$107K	89,400
2015-10-13	ACRSAclaris Therapeutics, Inc. · Series A Preferred StockC Conversion	10% Owner	CConversion	−8.47M sh	—	—	0
2015-10-13	ACRSAclaris Therapeutics, Inc. · Series A Preferred StockC Conversion	10% Owner	CConversion	−185K sh	—	—	0
2015-10-13	ACRSAclaris Therapeutics, Inc. · Series B Preferred StockC Conversion	10% Owner	CConversion	−1.78M sh	—	—	0
2015-10-13	ACRSAclaris Therapeutics, Inc. · Series B Preferred StockC Conversion	10% Owner	CConversion	−38.8K sh	—	—	0
2015-10-13	ACRSAclaris Therapeutics, Inc. · Series C Preferred StockC Conversion	10% Owner	CConversion	−29.3K sh	—	—	0
2015-10-13	ACRSAclaris Therapeutics, Inc.C Conversion	10% Owner	CConversion	+3.36M sh	—	—	3,657,147
2015-10-07	ACRSAclaris Therapeutics, Inc.P Purchase	10% Owner	PPurchase	+285 sh	$11.00	+$3,135	6,467
2015-10-07	ACRSAclaris Therapeutics, Inc.P Purchase	10% Owner	PPurchase	+13.1K sh	$11.00	+$144K	296,739
2015-07-21	Sierra Oncology, Inc.Series D Preferred StockC Conversion	Director, 10% Owner	CConversion	−2.06M sh	—	—	0
2015-07-21	Sierra Oncology, Inc.C Conversion	Director, 10% Owner	CConversion	+2.06M sh	—	—	2,064,308
2015-07-21	Sierra Oncology, Inc.C Conversion	Director, 10% Owner	CConversion	+45K sh	—	—	2,109,299
2015-07-21	Sierra Oncology, Inc.J Other	Director, 10% Owner	JOther	+107K sh	$5.21	+$556K	2,215,946
2015-07-21	Sierra Oncology, Inc.J Other	Director, 10% Owner	JOther	+2,324 sh	$5.21	+$12.1K	2,218,270
2015-07-21	Sierra Oncology, Inc.P Purchase	Director, 10% Owner	PPurchase	+215K sh	$17.00	+$3.66M	2,433,577
2015-07-21	Sierra Oncology, Inc.P Purchase	Director, 10% Owner	PPurchase	+4,693 sh	$17.00	+$79.8K	2,438,270
2015-07-21	Sierra Oncology, Inc.Series D Preferred StockC Conversion	Director, 10% Owner	CConversion	−45K sh	—	—	0
2015-03-24	LITSLite Strategy, Inc. · Warrant to Purchase Common StockO Exercise Out-of-Money	10% Owner	OExercise Out-of-Money	+420K sh	—	—	0
2015-03-24	LITSLite Strategy, Inc.O Exercise Out-of-Money	10% Owner	OExercise Out-of-Money	+455K sh	$3.12	+$1.42M	3,553,677
2013-10-29	LITSLite Strategy, Inc.S Sale	10% Owner	SSale	−756 sh	$8.27	−$6,252.12	3,098,503
2013-10-28	LITSLite Strategy, Inc.S Sale	10% Owner	SSale	−39K sh	$8.30	−$323K	3,099,259
2013-10-25	LITSLite Strategy, Inc.S Sale	10% Owner	SSale	−260K sh	$8.20	−$2.13M	3,138,212

Recent filings

Accepted (ET)
Aug 314
VIVO VENTURES VII, LLC0001615774-18-009063
SEC(opens sec.gov)
Mar 24
Aclaris Therapeutics, Inc.0001615774-17-000876
SEC(opens sec.gov)
Nov 184
Aclaris Therapeutics, Inc.0001615774-16-008485
SEC(opens sec.gov)
Sep 124
CODEXIS INC0001225208-16-039231
SEC(opens sec.gov)
Aug 174
CODEXIS INC0001225208-16-038071
SEC(opens sec.gov)
Aug 54
CODEXIS INC0001225208-16-037558
SEC(opens sec.gov)

Companies

Address

575 HIGH STREET, SUITE 201

PALO ALTO, CA, 94301